Skip to main content

Table 5 Response to treatment according to anatomic classification of autoimmune uveitis

From: Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center

Treatment Remission Improvement Worsening
( n , %) (45 pts, 43.3%) (28 pts, 26.9%) (31 pts, 29.8%)
Anterior Intermediate Posterior Panuveitis Anterior Intermediate Posterior Panuveitis  
Corticosteroids (5, 4.8) 2   1   1     1
Corticosteroids + Azathioprine (36, 34.6) 9 1    7 1 2 1 15
Corticosteroids + Cyclosporin-A (35, 34.6) 1 1 8   2 1 8 1 12
Corticosteroids + Cyclophosphamide (8, 7.6)    3 1    1 1 2
Corticosteroids + Methotrexate (2, 1.9) 1   1       1
Corticosteroids + combined immuno-suppressive therapy (8, 7.6) 1 1 2 2    1 1  
Anti-tumor necrosis factor-α (7, 6.7) 1   3 3      0
Anti-vascular endothe-lial growth factor (3, 2.9)    2 1      0